 - Postmenopausal women with disease recurrence while receiving either tamoxifen or a non-steroidal aromatase inhibitor AI as adjuvant therapy as long as adjuvant hormonal therapy was taken for 6 months before disease progression or with disease recurrence following the discontinuationcompletion of adjuvant hormonal therapy 